Oncolytics Biotech’s® Chinese Development Partner Adlai Nortye Presents Interim Clinical Data Further Demonstrating the Anti-Cancer Activity of Pelareorep-Paclitaxel Combination Therapy in HR+/HER2- Metastatic Breast Cancer at the San Antonio Breast Cancer Symposium

December 8, 2022

Biotechnology

Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million

April 18, 2024
Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study

April 16, 2024
SciSparc to Acquire AutoMax

April 11, 2024
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs

April 11, 2024